4 Stocks Attracting Top Investors

By Motley Fool Staff | More Articles
January 28, 2009 | Comments (2)

There's a reason why more than 30,000 investors flock to Omaha each May, and millions more rummage through the Berkshire Hathaway annual reports: Gleaning knowledge from proven investors is one way to find the stocks that will make you rich.

Using Motley Fool CAPS, the Fool's 125,000-plus-member investing community, we can see which stocks are receiving a boost in attention from CAPS All-Star players each week. A sudden increase in bullish interest from top-rated investors could signal that the stock deserves further research.

Here are four stocks receiving more support from CAPS All-Stars over the past month:

Company	Industry	% Change in All-Star Bulls From 12/29 to 1/28	CAPS Research
StemCells, Inc. (Nasdaq: STEM )	Biotechnology	93%	STEM
ION Geophysical Corporation (NYSE: IO )	Energy Equipment and Services	91%	IO
Direxion Shares ETF Trust Large Cap Bull 3x (NYSE: BGU )	Funds	87%	BGU
State Street Corp (NYSE: STT )	Capital Markets	81%	STT

Source: Motley Fool CAPS, as of Jan. 28, 2009.

Come join us on CAPS, absolutely free, to learn more about these and countless other interesting stock ideas. Sign up for free.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Disclosure is important to us here at The Motley Fool. No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Motley Fool PRO, and Ready Made Millionaire services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Report this Comment On January 28, 2009, at 2:50 PM, deeogeew wrote:

If investors are flocking to these 4 stocks, such as stemcells, why has it dropped so much in price. When can we expect an improvement?
Report this Comment On January 30, 2009, at 4:57 PM, TxTom wrote:

STEM is poised to go higher. Each day brings unusually large volume, higher highs and higher lows, and there are many catalysts including: the GERN clinical trials, possible clinicals by STEM, government likelihood of financing stem cell research (an immedicate boost when that happens), promising research results to date, and maybe most importantly the focusing of investors on this sector. Look at recent share price increases.And this doesn't even assume the possible purchase by a large pharma. Lots of upside, lack of apparent downside. My kind of stock!